Skip to content
AwardedSpainGoods€2,880,263

Suministro de Medicamentos Exclusivos con Principios activos Bimekizumab, Fenfluramina, Inebilizumab, Lumasiran, Mirikizumab, Pitolisant, Tafasitamab, Tensioactivo Pulmonar Porcino, Tuberculina, Velmanasa y Vutrisiran de los laboratorios farmacéuticos Alnylam Pharmaceuticals Spain, S.L., Amgen, S.A., Biomarin Pharmaceuticals España, S. L., Chiesi España, S.A.U., Incyte Biosciences Iberia, S.L., Li

Published
Published 30 October 2025

Overview

Medicamentos Exclusivos con Principios activos Bimekizumab, Fenfluramina, Inebilizumab, Lumasiran, Mirikizumab, Pitolisant, Tafasitamab, Tensioactivo Pulmonar Porcino, Tuberculina, Velmanasa y Vutrisiran

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€2,880,263
Procedure
Direct
Published
30 October 2025
Classification (CPV)
Medicinal products for the alimentary tract and metabolismMineral supplementsMedicinal products for the musculo-skeletal systemAntineoplastic agentsImmunosuppressive agentsAntiepilepticsOther nervous system medicinal productsMedicinal products for the respiratory system+1 more

Award outcome

Awarded value
€10,353,452
Award date
23 September 2025
Winners
  • ALNYLAM PHARMACEUTICALS SPAIN, S.L.
  • AMGEN, S.A.
  • BIOMARIN PHARMACEUTICALS ESPAÑA, S.L.
  • CHIESI ESPAÑA, S.A.U.
  • INCYTE BIOSCIENCES IBERIA, S.L.
  • LILLY, S.A.
  • MEDICARE PHARMA, S.L.
  • UCB PHARMA, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    30 October 2025

Contracting authority

  • Servicio Murciano de Salud - Junta de Compras

    Procuring entity

    Espinardo, Spain

    ID_PLATAFORMA: 41261690169929

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de Medicamentos Exclusivos con Principios activos Bimekizumab, Fenfluramina, Inebilizumab, Lumasiran, Mirikizumab, Pitolisant, Tafasitamab, Tensioactivo Pulmonar Porcino, Tuberculina, Velmanasa y Vutrisiran de los laboratorios farmacéuticos Alnylam Pharmaceuticals Spain, S.L., Amgen, S.A., Biomarin Pharmaceuticals España, S. L., Chiesi España, S.A.U., Incyte Biosciences Iberia, S.L., Li — won by ALNYLAM PHARMACEUTICALS SPAIN, S.L. +7 — Skim